Esperion Therapeutics stock remains a buy as strong drug franchises, growth, and global milestones outweigh risks. Learn more ...

Record operating cash flow (before working capital adjustments) for the three months ended September 30, 2025, of $101.8 ...

K92 Mining Inc. ("K92" or the "Company") (TSX: KNT; OTCQX: KNTNF) is pleased to announce financial results for the three and ...

Explore our Q3 2025 analysis on why high-quality international stocks are underperforming and see our latest portfolio ...

Transparency earns trust. When franchisors share clear, actionable data and coach teams to use it, operators make faster, ...

During Meta's third-quarter earnings call last week, CEO Mark Zuckerberg spent quite a bit of time detailing the company's AI ...

How thinking like a buyer of your own company creates better strategic decisions—even when you never plan to sell.

AI has the potential to transform enterprises, but the differentiator is not technical brilliance. It is the ability to align people, processes and governance with business priorities. Models and ...

Recognition reflects its success in redefining global CX outsourcing through innovation, strategy, and performance excellence. SAN ANTONIO, Nov. 10, 2025 /PRNewswire/ ...